Language Minimizing Adverse Events; HPV and Thyroid Cancer; Ultrasound Bras News, features, and commentary about cancer-related issues Jan 05, 2024
Study Assuages Fears of Pancreatic Cancer Risk With GLP-1 Receptor Agonists Researchers looked at 7-year patient data Jan 04, 2024
Futile Immunotherapy for Cancer Grows More Common Occurs most often at non-academic and low-volume centers Jan 04, 2024
Lessons From the Chemotherapy Shortages: Invest in Generics We need more sustainable solutions to ensure treatment access Dec 31, 2023
Cancer Patients Face Frightening Delays in Treatment Approvals "For them to take weeks -- up to months -- to provide an authorization is ridiculous" Dec 30, 2023
Another CAR-T Warning; 'Sweet' Cancer Test; 'Molecular Jackhammer' Blows Up Cancer News, features, and commentary about cancer-related issues Dec 28, 2023
Mind of the 'Maestro': Inside the Head of Leonard Bernstein Psychiatrist and concert pianist Richard Kogan, MD, on the great composer's complex inner life Dec 27, 2023
Significant Left Nasal Obstruction Finally Diagnosed After 2 Years Nonspecific presentation impedes early diagnosis of rare indolent tumor in older man Dec 26, 2023
Mammo Responsibility Ups Screening; Opioids for Cancer Pain? Ignored Signs of CRC News, features, and commentary about cancer-related issues Dec 21, 2023
Homelessness Tied to Worse Cancer Outcomes Among Veterans However, all-cause mortality rates in lung, colon cancer lower versus other healthcare settings Dec 21, 2023
Psilocybin May Help Ease Depression in Cancer Patients In small trial, half had early remission of depressive symptoms after psilocybin-assisted therapy Dec 18, 2023
National Database Study Finds Higher Risk for Barrett’s Esophagus in IBD But no greater chance of BE-tied malignancy for these patients Dec 16, 2023
FDA Approves New First-Line Standard of Care in Bladder Cancer Enfortumab vedotin plus pembrolizumab doubled survival as compared with chemotherapy Dec 15, 2023
Andre Braugher's Cancer Dx; Malignancies Rising in Younger Adults; Negative Trials News, features, and commentary about cancer-related issues Dec 14, 2023
FDA OKs Maintenance Option for High-Risk Neuroblastoma Eflornithine approved to reduce relapse risk in both kids and adults Dec 14, 2023
'Half-Matched' BMTs Effective in Severe Sickle Cell Disease High survival rates observed in patients not normally suitable for transplant Dec 13, 2023
Lenvatinib-Pembrolizumab Combo Misses Goal in First-Line HCC Trial Numerical advantages in OS, PFS fall short of statistical significance Dec 13, 2023
EUS-Guided Gastroenterostomy Better Option for Cancer-Related Duodenal Blockages However, technique and technology are not widespread Dec 08, 2023
Detecting Ovarian Cancer Early; Allergy Med for NSCLC? Bad News for Anti-TIGIT Drug News, features, and commentary about cancer-related issues Dec 07, 2023
Novel Therapy Reduced Transfusion Dependence in Lower-Risk MDS 40% of patients treated with imetelstat were transfusion-free for at least 8 weeks Dec 04, 2023
First Gene Therapy for Non-Muscle-Invasive Bladder Cancer Offers Durable Response A quarter patients with high-risk, BCG-unresponsive disease were recurrence free at 3 years Dec 04, 2023
Charting the Course: From Young Adult Leukemia Patient to Oncologist My experience shaped how I care for patients today Dec 03, 2023
Let's Talk Drug Prices; Restoring the Sense of Touch; Learning From Tumors in a Dish News, features, and commentary about cancer-related issues Dec 01, 2023
Oncolytic Virus Shows High Response Rates in BCG-Unresponsive Bladder Cancer Results from interim analysis suggest "potential to disrupt the NMIBC treatment landscape" Dec 01, 2023
Noninvasive Therapy Shows Efficacy in Non-Muscle-Invasive Bladder Cancer Investigational intravesical solution led to complete response rate of 79% Nov 30, 2023
Combining Immunotherapy and PARP Inhibition in Advanced Uterine Cancer And our roundtable of experts discuss selinexor for wild-type p53 disease Nov 30, 2023 video
FDA Approves First Therapy for Progressive Desmoid Tumors Nirogacestat reduced the risk of disease progression or death by 71% in randomized trial Nov 28, 2023
Chemoimmunotherapy Improves Pathologic Outcomes in Gastroesophageal Carcinoma Adding atezolizumab to FLOT led to more downstaging, complete regressions versus chemo alone Nov 24, 2023
Cancer Drug Recall; Long COVID and Reinfection; WHO Staffer Killed in Gaza Health news and commentary from around the Web gathered by MedPage Today staff Nov 22, 2023
Nudging Parents Plus Auditing Providers Increased HPV Vaccine Uptake in Tweens Interventions worked best in combination, according to cluster randomized trial Nov 20, 2023
Shooting at Psych Hospital; Rosalynn Carter Dies; Millions in Medical Debt Canceled Health news and commentary from around the Web gathered by MedPage Today staff Nov 20, 2023
Reprogramming Tumors; Bad Stool Samples; Human Experiences in Cancer Care News, features, and commentary about cancer-related issues Nov 17, 2023
Pancreatic Cancer Doesn't Have to Be a Death Sentence Early detection is the key to increasing survival rates Nov 13, 2023
Zoonotic Spillovers; DNA and RNA Testing for Cancer Risk Also in TTHealthWatch: genes and health conditions among Icelanders Nov 11, 2023 podcast
Vitamin D for Neuropathy; Good & Bad News for CAR-T; New Labeling for Surgical Mesh News, features, and commentary about cancer-related issues Nov 10, 2023
Moving Beyond the 'Angelina Jolie Effect' to Address Cancer Disparities A "local heroes effect" can better reach communities of color Nov 09, 2023
Novel Therapies Show Early Promise in Advanced Gastroesophageal Cancers Results look good, but more data needed Nov 08, 2023
Senate Confirms Monica Bertagnolli as Next NIH Director Vote was 62-36 in favor of the current National Cancer Institute director Nov 07, 2023
FDA Panel Backs High-Risk Designation for Salvaged Blood Irradiators With Class III designation, sponsors would have to prove safety, efficacy with randomized trials Nov 07, 2023
T-DXd Tied to Encouraging Survival in HER2-Expressing Gyn Cancers More responses, longer OS in subset with the highest levels of HER2 expression Nov 07, 2023
